Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amorolfine new formulation nail lacquer for distal and lateral subungual toenail onychomycosis
2006-000974-54Phase 2Completed
- Sponsor
- Galderma
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amorolfine in onychomycosis (4 arms), sponsored by Galderma. Started Apr 2006; status: completed.
02
Drugs
amorolfine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2006-000974-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000974-54.